Biotech news
Biotech
An intervention by Russia’s IP ombudsman seeks to solve the validity issue over secondary patents, but is it needed, asks Maxim Sobolev of Rouse. 30 September 2019
Biotech
There is no doubting the importance of next year’s CRISPR appeal, but any conclusions about the parties’ prior art have consequences for elsewhere too, say Catherine Coombes and Emma Longland of HGF. 30 September 2019
Biotech
The Actavis v ICOS UK Supreme Court judgment was a bitter pill to swallow, but is it really the end of dosage patents? Richard Wells and Stephanie Pilkington of Potter Clarkson review the situation. 30 September 2019
Americas
Filing a divisional patent application in Brazil needs a keen understanding of the process and flexibility in the system, as Kene Gallois and Luis Felipe Maciel da Silva of Daniel Law explain. 30 September 2019
Americas
The US Court of Appeals for the Federal Circuit has ruled that delays resulting from challenges to patent examiners’ final decisions will be attributed to the applicant when calculating patent term adjustment. 23 September 2019
Biotech
Advocate general Henrik Saugmandsgaard Øe has advised Europe’s highest court on the scope of protection held by owners of plant variety rights. 19 September 2019
Americas
The US Court of Appeals for the Federal Circuit has affirmed the US Patent and Trademark Office’s patent term adjustment of a Mayo Foundation-owned patent. 18 September 2019
Americas
A couple who worked at Ohio-based research institute Nationwide Children’s Hospital have been charged with stealing trade secrets and then using the information to market products through their Chinese company. 17 September 2019
Americas
Taiwanese company JHL Biotech will stop developing biosimilar versions of Genentech’s drugs as part of a memorandum of understanding signed by the parties to end trade secrets litigation. 10 September 2019
Pharma
Held during Boston’s week-long Biotech festival, BioPharm America promises its 4,500 delegates excellent knowledge, networking, and deal opportunities, says Guadalupe Rodriguez of EBD Group. 10 September 2019